
Assoc. Prof. Dr. Hoang Trung Vinh – Vietnam Military Medical Academy
Medications that may induce hyperglycemia
| No. | Drug Class/Name | Mechanism/Impact | Measures to mitigate hyperglycemic effects |
| 1 | Corticosteroids – Prednisolone – Dexamethasone – Methylprednisolone |
– Increase hepatic gluconeogenesis – Decrease insulin sensitivity – Primarily increase postprandial glucose |
– Use the lowest dose for the shortest duration (if possible) – Take in the morning (to reduce nocturnal glucose elevation) – Prioritize topical use: inhalation, ointment (if possible) – Monitor postprandial glucose – Temporary short-term insulin use (if necessary) |
| 2 | Diuretics – Hydrochlorothiazide – Furosemide |
– Decrease insulin secretion due to hypokalemia – Increase insulin resistance |
– Monitor serum potassium – Potassium supplementation if necessary – Consider switching to another suitable drug class if possible |
| 3 | Antipsychotics – Olanzapine – Clozapine – Risperidone |
– Weight gain – Severe insulin resistance – Risk of new-onset diabetes |
– Prioritize medications with less metabolic impact (if possible) – Monitor glucose and weight – Promote physical activity and dietary restriction |
| 4 | Immunosuppressants – Tacrolimus – Cyclosporine |
– Pancreatic beta-cell toxicity reducing insulin secretion – Decrease cell growth |
– Regular glucose monitoring – Adjust dose based on drug concentration – Coordinate with endocrine therapy when necessary |
| 5 | Beta-blockers – Propranolol – Atenolol |
– May cause mild glucose elevation, decrease insulin secretion – Mask symptoms of hypoglycemia (very dangerous) |
– Replace with highly selective beta-blockers such as: Metoprolol, Carvedilol, Nebivolol |
| 6 | Sympathomimetics Salbutamol |
– Increase glycogenolysis causing hyperglycemia – Increase gluconeogenesis – Stimulate free fatty acid release |
– Avoid high doses if possible – Prioritize inhalation route – Use intermittently if possible |
| 7 | Oral contraceptives: Estrogen ± Progestin (Ethinylestradiol) |
– Increase insulin resistance – Increase hepatic glucose production – Decrease insulin sensitivity – Impair glucose tolerance |
– Choose products with low estrogen content (< 35 mcg) or prioritize progestin-only pills (POP) – Consider non-hormonal contraception: condoms, IUDs – Periodic glucose monitoring |
| 8 | Other medications | ||
| Phenytoin | Decrease insulin secretion | Dose adjustment (reduction) or medication replacement | |
| Niacin (Vitamin B3) | Increase insulin resistance | – Titrate dose slowly – Use extended-release formulations (Niaspan) – Take with meals |
|
| Interferon | Induce autoimmune diabetes | – Dose adjustment (reduction) – Use insulin if hyperglycemia is prolonged – Periodic glucose monitoring |
Medications that may induce hypoglycemia
| No. | Drug Class/Name | Mechanism/Impact | Measures to mitigate hyperglycemic effects |
| 1 | Antibiotics – Quinolones: Levofloxacin, Ciprofloxacin – Sulfonamides: Trimethoprim / Sulfamethoxazole |
– Increase insulin secretion – Increase insulin sensitivity |
– Avoid use if alternatives exist (especially in elderly or diabetic patients) – Do not use concurrently with potent hypoglycemic agents (if possible) – Monitor glucose during treatment |
| 2 | Antimalarials: Quinine | Stimulate insulin secretion causing severe hypoglycemia | – If IV, must be infused slowly – Should be diluted with dextrose solution – Switch to oral route as soon as possible – Avoid excessively high doses – Periodic glucose monitoring |
| 3 | Cardiovascular drugs – Propranolol – ACE inhibitors (Enalapril) |
– Increase insulin sensitivity (ACEI) – Mask hypoglycemia symptoms (Beta-blockers) |
– Select selective beta-blockers (less impact) – Reduce dose of antidiabetic medications – Consider switching to Angiotensin II Receptor Blockers (ARBs) |
| 4 | Pentamidine (Antimicrobial for pneumonia) |
– Initial phase causes hypoglycemia due to excessive insulin release. – Subsequent phase causes hyperglycemia due to cell destruction. |
– Frequent glucose monitoring, ideally continuous (CGM). – Replace with aerosolized form. |
| 5 | Analgesics – Anti-inflammatory – High-dose Aspirin – Ibuprofen – Diclofenac – Naproxen |
– Increase insulin sensitivity – Interaction with antidiabetic drugs (SU) – Inhibit Prostaglandins – substances involved in glucose regulation |
– Use low doses or avoid in diabetic patients if possible – Use alternatives like Paracetamol – Avoid prolonged use – Adjust antidiabetic drug dosage appropriately |
General measures in clinical practice
– Thoroughly investigate adverse effects and drug interactions when glucose levels show unexplained fluctuations.
– Identify medications with the risk of inducing hyperglycemia/hypoglycemia.
– Timely adjust medications suspected of causing glucose fluctuations: Dose adjustment, especially for insulin.
– Individualize patient care:
+ Elderly patients: High risk of hypoglycemia.
+ Patients with liver/kidney disease: Reduced metabolism and elimination, increasing the risk of hypoglycemia.
– Regularly monitor glucose, including continuous monitoring (CGM if available), especially with high-dose corticosteroids or in severe clinical conditions.
– Dietary adjustment: Avoid rapid-acting sugars, use small frequent meals, do not skip meals.
– Patient education: Recognize signs of hyperglycemia/hypoglycemia, always carry rapid-acting sugar for emergencies (glucose tablets, candy).
REFERENCES
- Vasu, T. P., & Molitch, M. E. (2024). Medication-induced hyperglycemia and diabetes mellitus: A review of current literature and practical management strategies. Journal of Clinical Medicine, 13(16), Article 4834. https://doi.org/10.3390/jcm13164834
- Faillie, J.-L. (2024). Drug-induced hyperglycemia and diabetes. Therapie, 79(2), 145–152. https://doi.org/10.1016/j.therap.2023.10.005
- Swenson, A. J., Smith, K. L., & Roberts, R. E. (2025). Non-diabetic hypoglycemia: Evaluation and management in adults. Journal of Clinical Medicine, 14(1), Article 4393. https://doi.org/10.3390/jcm14014393
Vietnam Association of Diabetes and Endocrinology – VADE Vietnam Association of Diabetes and Endocrinology – VADE